Floatz logo

149 assets in Primary Peritoneal Carcinoma

Therapeutic assets addressing Primary Peritoneal Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Dostarlimab
Primary Peritoneal Carcinoma
AGO Research GmbHP2CCC (55)
Fianlimab
Primary Peritoneal Carcinoma
Regeneron PharmaceuticalsP2CCC (55)
Gm-Csf
Primary Peritoneal Carcinoma
Roswell Park Cancer InstituteP2CCC (55)
Imiquimod
Primary Peritoneal Carcinoma
Toray Industries, IncP2CCC (55)
Sarilumab
Primary Peritoneal Carcinoma
Regeneron PharmaceuticalsP2CCC (55)
Senaparib
Primary Peritoneal Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2CCC (55)
Talazoparib
Primary Peritoneal Carcinoma
M.D. Anderson Cancer CenterP1/2CCC (55)
Ubamatamab
Primary Peritoneal Carcinoma
Regeneron PharmaceuticalsP2CCC (55)
Bl-M07D1
Primary Peritoneal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3CCC (54)
Dexasone
Primary Peritoneal Carcinoma
Merck Sharp & Dohme LLCP3CCC (54)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide
Primary Peritoneal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P3CCC (54)
Olvimulogene Nanivacirepvec
Primary Peritoneal Carcinoma
Genelux CorporationP3CCC (54)
rc88
Primary Peritoneal Carcinoma
RemeGen Co., Ltd.P2CCC (54)
Sacituzumab Tirumotecan
Primary Peritoneal Carcinoma
Merck Sharp & Dohme LLCP3CCC (54)
Adsorbed Purified Pertussis Vaccine
Primary Peritoneal Carcinoma
Mayo ClinicP2CCC (53)
Alpelisib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Anastrozole
Primary Peritoneal Carcinoma
Jonsson Comprehensive Cancer CenterP2CCC (53)
Anetumab Ravtansine
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Apsolol
Primary Peritoneal Carcinoma
Memorial Sloan Kettering Cancer CenterP1CCC (53)
Binimetinib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Ceralasertib
Primary Peritoneal Carcinoma
M.D. Anderson Cancer CenterP2CCC (53)
Cilostazol
Primary Peritoneal Carcinoma
Emory UniversityP2CCC (53)
Copanlisib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Diphtheria Toxoid
Primary Peritoneal Carcinoma
Mayo ClinicP2CCC (53)
Diphtheria Toxoid Adsorbed
Primary Peritoneal Carcinoma
Mayo ClinicP2CCC (53)
Disitamab
Primary Peritoneal Carcinoma
Peking University Cancer Hospital & InstituteP2CCC (53)
Dpx-Survivac
Primary Peritoneal Carcinoma
University Health Network, TorontoP2CCC (53)
Gotistobart
Primary Peritoneal Carcinoma
OncoC4, Inc.P2CCC (53)
Lenvatinib
Primary Peritoneal Carcinoma
Floor Backes, MDP2CCC (53)
Lorigerlimab
Primary Peritoneal Carcinoma
MacroGenicsP2CCC (53)
Neratinib Maleate
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nilotinib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Pegcetacoplan
Primary Peritoneal Carcinoma
Roswell Park Cancer InstituteP2CCC (53)
Sotorasib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Stapuldencel
Primary Peritoneal Carcinoma
Peking University Third HospitalP2CCC (53)
Tetanus Toxoid
Primary Peritoneal Carcinoma
Mayo ClinicP2CCC (53)
Vismodegib
Primary Peritoneal Carcinoma
Ronald BuckanovichP2CCC (53)
Cdx 1140
Primary Peritoneal Carcinoma
Roswell Park Cancer InstituteP2CCC (52)
Nemvaleukin
Primary Peritoneal Carcinoma
Mural Oncology, IncP3CCC (52)
Upifitamab Rilsodotin
Primary Peritoneal Carcinoma
Mersana TherapeuticsP3CCC (52)
Aitua Combination Antibody
Primary Peritoneal Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP2CCC (51)
Azenosertib
Primary Peritoneal Carcinoma
OHSU Knight Cancer InstituteP1/2CCC (51)
Benmelstobart
Primary Peritoneal Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (51)
hs-20089
Primary Peritoneal Carcinoma
Hansoh BioMedical R&D CompanyP2CCC (51)
Panitumumab
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)P2CCC (51)
Romiplostim
Primary Peritoneal Carcinoma
Peking University People's HospitalP2CCC (51)
Tretinoin
Primary Peritoneal Carcinoma
Peking University People's HospitalP2CCC (51)
Utidelone
Primary Peritoneal Carcinoma
Beijing Biostar Pharmaceuticals Co., Ltd.P2CCC (51)
Polyethyleneglycol-7-Ethyl-10-Hydroxycamptothecin Dfp-13318
Primary Peritoneal Carcinoma
Mayo ClinicP2CCC (50)
Pumvc3-Higfbp-2 Multi-Epitope Plasmid Dna Vaccine
Primary Peritoneal Carcinoma
University of WashingtonP2CCC (50)
Showing 51 to 100 of 149 assets
PreviousPage 2 of 3Next